Miriam C. Poirier

Transplacental Effects of 3'-Azido-2',3'-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and Monkeys

Ofelia A. Olivero, Stuart H. Yuspa, Miriam C. Poirier et al. · JNCI Journal of the National Cancer Institute · 1997 · 227 citations · Full text

Pharmacy, Pharmacology, Toxicology +16

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

E Reed, Robert F. Ozols, Robert E. Tarone et al. · Proceedings of the National Academy of Sciences · 1987 · 220 citations · Full text

Medicine, Oncology, Pharmacology +15

Long-Term Mitochondrial Toxicity in HIV-Uninfected Infants Born to HIV-Infected Mothers

Miriam C. Poirier, Rao L. Divi, Lena Al‐Harthi et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 185 citations

Pharmacy, Molecular Biology, Toxicology +17

A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene — DNA adducts in animal and human tissues by immunoassays

Frederica P. Perera, Miriam C. Poirier, Stuart H. Yuspa et al. · Carcinogenesis · 1982 · 167 citations

Pharmacy, Oncology, Toxicology +17

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

E Reed, Stuart H. Yuspa, Leonard A. Zwelling et al. · Journal of Clinical Investigation · 1986 · 158 citations · Full text

Medicine, Oncology, Pharmacology +13